1-20 of 147
Authors: G Van Assche
Save search
Sort by
Journal Article

P219 Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients

PDF
L Fierens and others
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S250–S252, https://doi.org/10.1093/ecco-jcc/jjz203.348
Published: 15 January 2020
Journal Article

OP37 Fibrogenesis in chronic DSS colitis is driven by an innate lymphoid cell-independent innate immune response

PDF
B Creyns and others
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S038–S039, https://doi.org/10.1093/ecco-jcc/jjz203.036
Published: 15 January 2020
Journal Article

DOP83 Intestinal fibrosis in Crohn’s disease patients is marked by up-regulation of innate immune cells and mucosal B cells

PDF
B Creyns and others
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S122–S123, https://doi.org/10.1093/ecco-jcc/jjz203.122
Published: 15 January 2020
Journal Article

P001 Multi-omic data integration assisted identification of molecular features contributing to disease heterogeneity in Crohn's disease Get access

PDF
P Sudhakar and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S085–S086, https://doi.org/10.1093/ecco-jcc/jjy222.125
Published: 25 January 2019
Journal Article

DOP37 Vedolizumab-induced endoscopic remission in anti-TNF exposed and anti-TNF naïve IBD patients: a large single-centre experience Get access

PDF
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S047–S048, https://doi.org/10.1093/ecco-jcc/jjy222.071
Published: 25 January 2019
Journal Article

DOP47 Sustained remission in patients with moderate to severe ulcerative colitis: Results from the Phase 3 UNIFI maintenance study Get access

PDF
G Van Assche and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S054–S055, https://doi.org/10.1093/ecco-jcc/jjy222.081
Published: 25 January 2019
Journal Article

OP37 Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI Get access

PDF
W J Sandborn and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S025–S026, https://doi.org/10.1093/ecco-jcc/jjy222.034
Published: 25 January 2019
Journal Article

P820 Molecular changes in non-inflamed terminal ileum in patients with ulcerative colitis Get access

PDF
H-S Lee and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S533–S534, https://doi.org/10.1093/ecco-jcc/jjy222.944
Published: 25 January 2019
Journal Article

P312 Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate–severe ulcerative colitis: UNIFI Get access

PDF
B E Sands and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S256–S257, https://doi.org/10.1093/ecco-jcc/jjy222.436
Published: 25 January 2019
Journal Article

P827 Up-regulation of IL17-related pathways in affected colon from ulcerative colitis compared with Crohn’s disease Get access

PDF
S Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S537–S538, https://doi.org/10.1093/ecco-jcc/jjy222.951
Published: 25 January 2019
Journal Article

DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients Get access

PDF
B Creyns and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S040, https://doi.org/10.1093/ecco-jcc/jjy222.061
Published: 25 January 2019
Journal Article

DOP38 A vedolizumab specific four-gene colonic signature accurately predicting future endoscopic remission in patients with inflammatory bowel disease Get access

PDF
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S048, https://doi.org/10.1093/ecco-jcc/jjy222.072
Published: 25 January 2019
Journal Article

DOP54 Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial Get access

PDF
S Danese and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S061–S062, https://doi.org/10.1093/ecco-jcc/jjy222.088
Published: 25 January 2019
Journal Article

P155 Adherence to quality indicators among patients with inflammatory bowel disease: an international comparative analysis Get access

PDF
A Weizman and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S166–S167, https://doi.org/10.1093/ecco-jcc/jjy222.279
Published: 25 January 2019
Journal Article

P311 Pharmacokinetics and exposure–response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study Get access

PDF
O J Adedokun and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S255–S256, https://doi.org/10.1093/ecco-jcc/jjy222.435
Published: 25 January 2019
Journal Article

P821 Distinct and common gene expression profiles between inflamed ileum and colon of newly diagnosed CD patients Get access

PDF
S Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S533, https://doi.org/10.1093/ecco-jcc/jjy222.945
Published: 25 January 2019
Journal Article

P032 Hepatocyte growth factor and MET in ulcerative colitis, novel drug targets impairing neutrophil recruitment? Get access

PDF
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S102, https://doi.org/10.1093/ecco-jcc/jjy222.156
Published: 25 January 2019
Journal Article

P542 Efficacy and safety of biological therapies in chronic antibiotic-refractory pouchitis: a retrospective single-centre experience Get access

PDF
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S385, https://doi.org/10.1093/ecco-jcc/jjy222.666
Published: 25 January 2019
Journal Article

P385 TREM1, the first anti-TNF specific biomarker guiding therapeutic decision Get access

PDF
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S300, https://doi.org/10.1093/ecco-jcc/jjy222.509
Published: 25 January 2019
Journal Article

DOP70 An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's disease Get access

PDF
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S072–S073, https://doi.org/10.1093/ecco-jcc/jjy222.104
Published: 25 January 2019